News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Civitas Therapeutics to Present at Wedbush Securities and Canaccord Genuity Investor Conferences in August


8/7/2013 9:00:36 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson’s disease that leverages the ARCUS(TM) respiratory delivery platform, today announced that Glenn Batchelder, President and Chief Executive Officer, will present a corporate update at the 2013 Wedbush Securities Life Sciences Management Access Conference and the Canaccord Genuity 33rd Annual Growth Conference. Additional details regarding the presentations are listed below.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES